Synthesis, anticancer activity and molecular docking of new pyrazolo[1,5-a]pyrimidine derivatives as EGFR/HER2 dual kinase inhibitors
G. Sivaiah, R. Raveesha, S. Prasad, K. Yogesh Kumar, M.S. Raghu, Fahd Alharethy, M.K. Prashanth, Byong‐Hun Jeon
Topics & Concepts
ChemistryDocking (animal)CytotoxicityEGFR inhibitorsPyrimidineEpidermal growth factor receptorKinaseStereochemistryIC50SorafenibPharmacologyCombinatorial chemistryBiochemistryIn vitroCancer researchReceptorHepatocellular carcinomaMedicineNursingBiologySynthesis and biological activityCancer therapeutics and mechanismsQuinazolinone synthesis and applications